Apelacio, Alvie T.

HRN: 21-65-09  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2022
CEFTRIAXONE 1G (VIAL)
07/27/2022
08/02/2022
IV
2grams
OD
Biliary Infection
Waiting Final Action 
07/27/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/27/2022
08/02/2022
IV
500mg
Q8hrs
Biliary Infections
Waiting Final Action 
08/15/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/15/2022
08/22/2022
IV
600mg
Q6
Abscess Right Lower Lip
Waiting Final Action 
08/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/15/2022
08/22/2022
IV
500mg
Q8
Abscess Right Lower Lip
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: